Brookline, MA, United States of America

Louise A Koopman

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biogen Idec Ma Inc.. Active years: 2011-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louise A Koopman. Retrieved from https://idiyas.com/inventor/louise-a-koopman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Chestnut Hill, MA (US) (2013)
  • Brookline, MA (US) (2011 - 2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Louise A. Koopman: Innovating in Cell Biology and Oncology**

Introduction

Louise A. Koopman, based in Brookline, MA, is a notable inventor with a remarkable contribution to fields such as cell biology, immunology, and oncology. With a total of four patents to her name, her work focuses on developing innovative treatments and diagnostic methods targeting cancer and various diseases.

Latest Patents

Louise's latest inventions include groundbreaking advancements involving humanized antibodies that recognize αβ integrins. These antibodies are composed of nonhuman variable regions alongside human immunoglobulin portions. Her patents elaborate on methods for treating, diagnosing, and preventing diseases, particularly through the use of these humanized anti-αβ antibodies. Furthermore, her discoveries also encompass identifying the differential expression of integrin αβ on tumor cells, which is instrumental in assessing the metastatic potential of these cells.

Additionally, her research has led to significant findings regarding SMAD4-deficient cancers. She has contributed methods to determine the responsiveness of tumor cells, especially those originating from pancreatic carcinomas, to αβ-active compounds. This research entails the interplay between the expression levels of the tumor suppressor gene SMAD4 and integrin αβ, which opens avenues for novel treatments focusing on tumor progression and the TGF-β pathway.

Career Highlights

Louise A. Koopman currently works at Biogen Idec MA Inc., a company renowned for its commitment to developing therapies for neurological diseases. Her role as an inventor highlights her dedication to advancing healthcare solutions through innovative research and development.

Collaborations

Throughout her career, Louise has collaborated with skilled professionals, including Shelia Marie Violette and Kenneth J. Simon. These partnerships have undoubtedly enriched her research endeavors and expanded her impact in the scientific community.

Conclusion

Louise A. Koopman's inventive spirit and unwavering commitment to the fields of cell biology and oncology are evident through her significant contributions and patents. Her pioneering work not only enhances our understanding of cancer treatment but also lays the groundwork for future innovations in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…